PRTN3 and rheumatoid arthritis: In order to illustrate the potential impact of cTRA2B antibodies in the diagnostic work-up of early RA patients, a score was generated based on adjusted and rounded odds ratios of the antibodies in a multivariable GLM (ACPA positivity 3 points, cTRA2B or RF positivity 1 point each).